The targeting focus of different slimming peptides
December 24, 2025
Different weight-loss peptides have slightly different targeting focuses.
GLP-1 receptor agonists (mainstream type): Focus on “appetite control + blood glucose regulation”, covering all the above 3 basic mechanisms, with mild fat loss and high safety.
Dual-receptor agonists (advanced type): Simultaneously activate GLP-1 and GIP receptors, with stronger appetite control and higher fat-burning efficiency, more suitable for stubborn obesity.
Other niche weight-loss peptides: Some target and inhibit fat synthesis (reduce adipocyte neogenesis) or accelerate energy consumption, with core logic still adhering to “physiology-aligned and precise targeting”.
Key Difference: Mechanism Gap vs Dieting/Laxatives (Why It’s Safer)
Dieting: Forcibly creates calorie deficit, breaks down muscle and lowers basal metabolic rate at the same time, disrupts physiological balance and easily causes rebound.
Laxatives: Eliminate water and intestinal contents through diarrhea, do not reduce fat, but also damage intestinal mucosa and cause electrolyte loss.
Weight-loss peptides: Align with the body’s natural physiological regulation, only intervene in metabolism, appetite and fat pathways, do not damage organs, and balance weight loss with health.
No. 1508-10, 15th Floor, One Meter Sunshine, No. 9 Sanquan Road, Jinshui District, Zhengzhou City, Henan Province
ABOUT US
Our company is dedicated to product excellence and customer-centric services, guided by innovation, professionalism, and win-win partnerships. We ensure efficient, reliable, and high-quality solutions to drive mutual success.
